Results 11 to 20 of about 6,682 (214)

Delphi consensus guidelines for the use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy for the diagnosis of dementia and mild cognitive impairment with Lewy bodies [PDF]

Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
INTRODUCTION The aim of this Delphi process was to develop consensus guidelines to support the effective use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy in the diagnosis of dementia with Lewy bodies and mild ...
Paul C. Donaghy, Gemma Greenfinch, George Petrides, Joseph Kane, Hein J. Verberne, John‐Paul Taylor, John T. O'Brien, Alan J. Thomas, DLB Indicative Imaging Biomarker Study Group   +8 more
doaj   +2 more sources

A case of adrenal endothelial cyst (vascular type) with positive 123I-MIBG uptake [PDF]

Urology Case Reports
123I-metaiodobenzylguanidine (MIBG) scintigraphy is highly accurate for diagnosing pheochromocytoma and paraganglioma (PPGL), and positive uptake in non-PPGL adrenal lesions is rare.
Riona Asai, Tomonori Sato, Yuto Yamazaki, Yuta Tezuka, Yoshikiyo Ono, Hiromichi Katayama, Yohei Satake, Takuma Sato, Yoshihide Kawasaki, Naoki Kawamorita, Hideki Katagiri, Akihiro Ito   +11 more
doaj   +2 more sources

[123I]-mIBG and [18F]-FDOPA differential uptake in the follow-up of neonatal neuroblastoma [PDF]

EJNMMI Reports
Single photon emission computed tomography (SPECT/CT) using meta-iodobenzylguanidine (mIBG) is currently recommended in pediatric clinical guidelines for assessing neuroblastoma.
Agathe Edet-Sanson, Marine Lechevallier, Romain Modzelewski, Stéphanie Becker, Anne-Charlotte Bouyeure-Petit, Pierre Bohn   +5 more
doaj   +2 more sources

Value of SPECT/CT in Diagnostic I-131 MIBG Scintigraphy in Patients with Neuroblastoma [PDF]

Nuclear Medicine and Molecular Imaging, 2018
Daris Theerakulpisut, Yutapong Raruenrom
exaly   +2 more sources

Investigation into cardiac sympathetic innervation during the commencement of haemodialysis in patients with chronic kidney disease [PDF]

, 2017
Background: Patients with chronic kidney disease (CKD) who undergo chronic haemodialysis (HD) show altered sympathetic tone, which is related to a higher cardiovascular mortality. The purpose of this study was to investigate the effect of transition from
Franssen, Casper F M, Glaudemans, Andor W J M, Goet, Esther R, Noordzij, Walter, Slart, Riemer H J A, Tio, René A, Özyilmaz, Akin   +6 more
core   +14 more sources

High clinical diagnostic accuracy of combined salivary gland and myocardial metaiodobenzylguanidine scintigraphy in the diagnosis of Parkinson’s disease

Frontiers in Aging Neuroscience, 2023
BackgroundDecreased myocardial uptake of 131I-metaiodobenzylguanidine (MIBG) is known to be an important feature to diagnose Parkinson’s disease (PD). However, the diagnosis accuracy of myocardial MIBG scintigraphy alone is often unsatisfying.
Shuangfang Li, Shuangfang Li, Lei Yue, Shuzhen Chen, Zhuang Wu, Jingxing Zhang, Ronghua Hong, Ludi Xie, Kangwen Peng, Chenghong Wang, Ao Lin, Lingjing Jin, Lingjing Jin, Lingjing Jin, Qiang Guan   +14 more
doaj   +1 more source

Two Cases of Hereditary Paraganglioma-Pheochromocytoma Syndrome in Siblings, Caused by a Novel Succinate Dehydrogenase Complex Subunit D Variant. [PDF]

IJU Case Rep
ABSTRACT Introduction Pheochromocytomas and paragangliomas are increasingly recognized as hereditary malignancies, with ~30%–40% of cases involving germline variants. We report a familial case of hereditary pheochromocytoma‐paraganglioma syndrome caused by a novel variant in the SDHD gene.
Nakamura R, Yamamoto Y, Kato T, Mukai K, Nomura M, Nojima S, Hatano K, Kakuta Y, Kawashima A, Nonomura N.   +9 more
europepmc   +2 more sources

Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson’s Disease: A Multicenter Study

Life, 2023
Background: Parkinson’s disease is a progressive neurodegenerative disorder, with incidence and prevalence rates of 8–18 per 100,000 people per year and 0.3–1%, respectively. As parkinsonian symptoms do not appear until approximately 50–60% of the nigral
Maria Silvia De Feo, Viviana Frantellizzi, Nicoletta Locuratolo, Arianna Di Rocco, Alessio Farcomeni, Caterina Pauletti, Andrea Marongiu, Julia Lazri, Susanna Nuvoli, Francesco Fattapposta, Giuseppe De Vincentis, Angela Spanu   +11 more
doaj   +1 more source

On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases. [PDF]

PLoS ONE, 2016
Abnormal cardiac uptake of 123I-metaiodobenzylguanidine (123I-MIBG) is a diagnostic marker of Lewy body diseases (LBDs), e.g., Parkinson's disease (PD) and dementia with Lewy bodies (DLB).
Hayato Odagiri, Toru Baba, Yoshiyuki Nishio, Osamu Iizuka, Minoru Matsuda, Kentaro Inoue, Akio Kikuchi, Takafumi Hasegawa, Masashi Aoki, Atsushi Takeda, Yasuyuki Taki, Etsuro Mori   +11 more
doaj   +1 more source

Diagnostic Use of Post-therapy ¹³¹I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma

Diagnostics, 2020
123I-meta-iodobenzylguanidine (123I-mIBG) scintigraphy is used for evaluating disease extent in children with neuroblastoma. 131I-mIBG therapy has been used for evaluation in children with high-risk neuroblastoma, and post-therapy 131I-mIBG scintigraphy ...
Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Raita Araki, Rie Kuroda, Norihito Akatani, Takafumi Yamase, Satoru Watanabe, Tomo Hiromasa, Yuji Kunita, Hiroshi Mori, Shintaro Saito, Yasuhiro Ikawa, Toshihiro Fujiki, Seigo Kinuya   +14 more
doaj   +1 more source